Modena, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 495
NA - Nord America 426
AS - Asia 120
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.043
Nazione #
US - Stati Uniti d'America 425
GB - Regno Unito 229
CN - Cina 109
SE - Svezia 65
DE - Germania 48
IE - Irlanda 43
IT - Italia 41
FR - Francia 32
FI - Finlandia 23
VN - Vietnam 5
UA - Ucraina 4
BE - Belgio 3
CH - Svizzera 2
EU - Europa 2
NL - Olanda 2
PH - Filippine 2
PL - Polonia 2
BD - Bangladesh 1
CA - Canada 1
IN - India 1
KR - Corea 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 1.043
Città #
Southend 223
Chandler 113
Woodbridge 90
Dublin 43
Ann Arbor 27
Beijing 26
Ashburn 22
Houston 21
Jacksonville 16
Lawrence 14
Princeton 14
Nanjing 13
Verona 12
Wilmington 9
Jinan 8
New York 8
Haikou 6
Hebei 6
Sindelfingen 6
Bologna 5
Redwood City 5
Shenyang 5
Zhengzhou 5
Changsha 4
Guangzhou 4
Helsinki 4
Taizhou 4
Brussels 3
Dearborn 3
Detroit 3
Fuzhou 3
Norwalk 3
Frankfurt am Main 2
Groningen 2
Jiaxing 2
Lanzhou 2
Lausanne 2
Ningbo 2
Nürnberg 2
Taiyuan 2
Trento 2
Austin 1
Chaoyang 1
Dhaka 1
Dong Ket 1
Hangzhou 1
Hefei 1
Kemerovo 1
Kochi 1
Leawood 1
Licata 1
London 1
Los Angeles 1
Markham 1
Milan 1
Nanchang 1
Ospedaletto Euganeo 1
Pavia 1
Rochester 1
Saarbrücken 1
Seattle 1
Tianjin 1
Totale 767
Nome #
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 97
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 93
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 93
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 88
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 87
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? 82
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 82
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice 77
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 74
The route to personalized medicine in bladder cancer: where do we stand? 73
AR-V7 and prostate cancer: The watershed for treatment selection? 69
Metabolic alterations in renal cell carcinoma 66
Kidney cancer and 2014: is innovation really over? 45
Metabolic Alterations in Renal and Prostate Cancer 44
Totale 1.070
Categoria #
all - tutte 3.223
article - articoli 3.223
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 3 16
2019/2020126 21 0 1 6 17 19 29 7 5 4 5 12
2020/202183 10 16 3 16 10 8 6 0 1 1 6 6
2021/202297 8 17 0 18 8 5 2 4 6 0 4 25
2022/2023278 18 33 23 49 23 67 0 26 29 2 7 1
2023/202483 6 6 10 10 23 9 2 11 3 3 0 0
Totale 1.070